Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Johan Ahlgren"'
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-9 (2024)
Abstract Background Population-based cancer quality registries are of great importance for the improvement of cancer care. However, little is known about the quality of recurrence data in cancer quality registries. The aim of this study was to evalua
Externí odkaz:
https://doaj.org/article/8a22e2da19584d688c78c1193fd482cb
Autor:
Matilda Appelgren, Helena Sackey, Yvonne Wengström, Karin Johansson, Johan Ahlgren, Yvette Andersson, Leif Bergkvist, Jan Frisell, Dan Lundstedt, Lisa Rydén, Malin Sund, Sara Alkner, Birgitte Vrou Offersen, Tove Filtenborg Tvedskov, Peer Christiansen, Jana de Boniface
Publikováno v:
Breast, Vol 63, Iss , Pp 16-23 (2022)
Introduction: This report evaluates whether health related quality of life (HRQoL) and patient-reported arm morbidity one year after axillary surgery are affected by the omission of axillary lymph node dissection (ALND). Methods: The ongoing internat
Externí odkaz:
https://doaj.org/article/c3a67ab10222469f89769b45423a329c
Autor:
Jana de Boniface, Jan Frisell, Yvette Andersson, Leif Bergkvist, Johan Ahlgren, Lisa Rydén, Roger Olofsson Bagge, Malin Sund, Hemming Johansson, Dan Lundstedt, on behalf of the SENOMAC Trialists’ Group
Publikováno v:
BMC Cancer, Vol 17, Iss 1, Pp 1-7 (2017)
Abstract Background The role of axillary lymph node dissection (ALND) has increasingly been called into question among patients with positive sentinel lymph nodes. Two recent trials have failed to show a survival difference in sentinel node-positive
Externí odkaz:
https://doaj.org/article/b044cb4b1bdb459780c39a8415765434
Purpose The safety of local estrogen therapy in patients on adjuvant endocrine treatment is questioned, but evidence on the issue is scarce. This nested case–control registry-based study aimed to investigate whether estrogen therapy affects breast
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d68b56e65d77e5861f7ba46b2e0b6571
http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-205015
http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-205015
Publikováno v:
Journal of Geriatric Oncology. 12:212-218
Objectives To study the treatment patterns, potential risk factors for hospitalization within one year from diagnosis, and causes of death in older patients with triple negative breast cancer (TNBC). Materials and Methods We performed a registry-base
Autor:
Therese M.-L. Andersson, Mark J. Rutherford, Hannah Bower, Paul W. Dickman, Johan Ahlgren, Paul C. Lambert, Mats Lambe, Elisavet Syriopoulou
Publikováno v:
The Breast. 45:75-81
Many studies have found evidence of socioeconomic differences in breast cancer survival. This study aimed to quantify the impact of removing differences in stage distribution and stage-specific relative survival between education groups in Swedish wo
Autor:
Johan Ahlgren, Maria Sund, Irma Fredriksson, Miguel Garcia-Argibay, Antonis Valachis, Anna-Karin Wennstig, Henrik Lindman, Hans Garmo
Publikováno v:
The Breast : Official Journal of the European Society of Mastology
Breast, Vol 59, Iss, Pp 157-164 (2021)
Breast, Vol 59, Iss, Pp 157-164 (2021)
Background Prior studies regarding use of Aromatase inhibitors (AIs) and risk for cardiovascular disease (CVD) have shown conflicting results. This retrospective cohort study aimed to investigate whether AIs use affects risk for CVD events in postmen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86767570357d6820db93af9c6cf190c7
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-456832
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-456832
Autor:
Grace Hsiao Hsuan Jen, Sven Törnberg, László Tabár, Sam Li Sheng Chen, Sherry Yueh Hsia Chiu, Chen Yang Hsu, Johan Ahlgren, Tony Hsiu Hsi Chen, Robert A. Smith, Lars Holmberg, May Mei Sheng Ku, Stephen W. Duffy, Håkan Jonsson, Peter B. Dean, Amy Ming-Fang Yen, Roberta Maroni
Background: Previously, the risk of death from breast cancer was analyzed for women participating versus those not participating in the last screening examination before breast cancer diagnosis. Consecutive attendance patterns may further refine esti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f245850dd32f94c996b5d8dbb3627c43
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-447101
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-447101
Autor:
Asgerdur Sverrisdottir, Kenneth Villman, Johan Ahlgren, Henrik Lindman, Carl Blomqvist, Jonas Bergh, Paula Poikonen-Saksela, Per Edlund, Søren Cold, Martin Andersson, Lars Stenbygaard, Troels Bechmann, Bent Ejlertsen, Lena Tennvall Nittby
Publikováno v:
Poikonen-Saksela, P, Lindman, H, Sverrisdottir, A, Edlund, P, Villman, K, Tennvall Nittby, L, Cold, S, Bechmann, T, Stenbygaard, L, Ejlertsen, B, Andersson, M, Blomqvist, C, Bergh, J & Ahlgren, J 2020, ' Leukocyte nadir as a predictive factor for efficacy of adjuvant chemotherapy in breast cancer. Results from the prospective trial SBG 2000-1 ', Acta Oncologica, vol. 59, no. 7, pp. 825-832 . https://doi.org/10.1080/0284186X.2020.1757149
Poikonen-Saksela, P, Lindman, H, Sverrisdottir, A, Edlund, P, Villman, K, Tennvall Nittby, L, Cold, S, Bechmann, T, Stenbygaard, L, Ejlertsen, B, Andersson, M, Blomqvist, C, Bergh, J & Ahlgren, J 2020, ' Leukocyte nadir as a predictive factor for efficacy of adjuvant chemotherapy in breast cancer. Results from the prospective trial SBG 2000–1 ', Acta Oncologica, vol. 59, no. 7, pp. 825-832 . https://doi.org/10.1080/0284186X.2020.1757149
Poikonen-Saksela, P, Lindman, H, Sverrisdottir, A, Edlund, P, Villman, K, Tennvall Nittby, L, Cold, S, Bechmann, T, Stenbygaard, L, Ejlertsen, B, Andersson, M, Blomqvist, C, Bergh, J & Ahlgren, J 2020, ' Leukocyte nadir as a predictive factor for efficacy of adjuvant chemotherapy in breast cancer. Results from the prospective trial SBG 2000–1 ', Acta Oncologica, vol. 59, no. 7, pp. 825-832 . https://doi.org/10.1080/0284186X.2020.1757149
Background: Retrospective studies have suggested that chemotherapy-induced leukopenia is associated with improved recurrence-free or overall survival. The SBG 2000–1 trial was designed to verify the favorable prognosis associated with chemotherapy-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::894f834caf497ceaa864d4c9c0e130f4
https://vbn.aau.dk/da/publications/d409389a-005e-4a1a-b899-33280889fc9c
https://vbn.aau.dk/da/publications/d409389a-005e-4a1a-b899-33280889fc9c
Publikováno v:
Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society. 110(3)
Purpose: To evaluate feasibility, quality of life, toxicity, and cosmetic outcome for intraoperative breast cancer brachytherapy after breast-conserving surgery using high dose rate brachytherapy. Methods: Fifty-two consecutive women, ⩾50 years old